Home
>
US Stocks
>
Immunogen, Inc.
Immunogen, Inc.
IMGN

Immunogen, Inc. (IMGN)

$5.92.43%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
5.73
Today Low/High
5.72 / 5.9
52 Week Low/High
$3.38 / $10.88
P/E ratio
-19.3413
Market Cap
$1.08B

Company Details

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, the company aims to disrupt the progression of cancer and offer its patients more good days.
Organisation
Immunogen, Inc.
Headquaters
Boston, Massachusetts, US
Employees
79
Industry
Health Technology
CEO
Mark Enyedy

Discover more

Frequently Asked Questions

What is Immunogen, Inc. (IMGN) share price today?

Can Indians buy Immunogen, Inc. (IMGN) shares?

How can I buy Immunogen, Inc. (IMGN) shares from India?

Can Fractional shares of Immunogen, Inc. (IMGN) be purchased?

What are the documents required to start investing in Immunogen, Inc. (IMGN) stocks?

We are a SEBI registered investement advisor